Efficacy of 2LPAPI®, a micro-immunotherapy drug, in patients with high-risk papillomavirus genital infection - Thomas, G; Cluzel, H; Lafon, J; Bruhwyler, J; Lajeune, B (Adv Infect Dis, 2016)